Bloom Diagnostics logo — Bloom’s proprietary technology allows for the quantitative m...

Bloom Diagnostics

Bloom’s proprietary technology allows for the quantitative measurement of markers from a drop of blood in real-time.

Founded 2018 Switzerland Zurich, Switzerland 13 employees Series B Total: $25.90M Health Care, Health and Wellness

General Information

Company Name Bloom Diagnostics
Founded Year 2018
Location Switzerland Zurich, Switzerland
Employees 13
Industries Health Care, Health and Wellness
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Bloom Diagnostics. To contact Bloom Diagnostics, visit bloomdiagnostics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Bloom Diagnostics compare?

A PDF of Bloom Diagnostics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Bloom Diagnostics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Bloom Diagnostics

Bloom Diagnostics is a Switzerland-based startup founded in 2018, operating in the Health Care and Health and Wellness industries. The company's slogan, "Bloom’s proprietary technology allows for the quantitative measurement of markers from a drop of blood in real-time," underscores its innovative approach. Bloom's proprietary technology enables the quantitative measurement of health markers from a single drop of blood, providing personalized health insights within minutes. Currently, Bloom offers tests for ferritin, thyroid, inflammation, and kidney health, with plans to expand its portfolio and technologies. In December 2022, Bloom Diagnostics secured a $1.20M Series B investment from Astor Perkins, signifying confidence in the company's vision and potential. This investment is a testament to the value perceived in Bloom's innovative technology and its potential to revolutionize personalized health diagnostics. As Bloom continues to develop and expand its offerings, the recent investment is expected to further propel its growth within the health tech sector.

Business keywords: Healthtech, Diagnostic Devices, At-Home Testing, Personalized Health, Finger-Prick Blood Tests, Health Reporting, Smart Blood Tests, Lateral Flow Immunoassay Technology, Healthcare Innovation

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $1.20M 1
Astor Perkins
20 Dec 2022
Series B $6.00M -
20 Nov 2021
Series B €10.00M 3
Speedinvest, Walter Ventures +1
31 May 2020
Series A €5.00M 2
Walter Ventures, Dutch L’Arche BV
31 May 2019
Seed Round €3.70M -
31 May 2018

Bloom Diagnostics Alternatives & Competitors

View All Alternatives
Bloom Diagnostics vs
cerascreen
cerascreen Germany

At cerascreen, we want you and your loved ones to stay healthy.

Seed
29 employees
Digital Health, Health Care
Bloom Diagnostics vs
BetterLabs
BetterLabs Denmark

Et godt liv starter med et godt helbred.

1 employees
Health Care, Health and Wellness
Bloom Diagnostics vs

Health data analytics made fun.

Seed
52 employees
AI, Health Care

FAQ About Bloom Diagnostics

Bloom’s proprietary technology allows for the quantitative measurement of markers from a drop of blood in real-time.
Bloom Diagnostics was founded in 2018.
Bloom Diagnostics is headquartered in Zurich, Switzerland.
Bloom Diagnostics operates in Health Care and Health and Wellness. Its work centres on Healthtech, Diagnostic Devices, At-Home Testing and Personalized Health.
Bloom Diagnostics has approximately 13 employees.
Bloom Diagnostics has completed 5 funding rounds, raising a total of $25.90M. The latest funding stage is Series B.
Top alternatives and competitors to Bloom Diagnostics include cerascreen, BetterLabs, Lili, Proov, Amina Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bloom Diagnostics and cerascreen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Bloom Diagnostics, https://bouncewatch.com/company/bloom-diagnostics, updated 24 March 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes